Real World Experiences: Pirfenidone and Nintedanib are Effective and Well Tolerated Treatments for Idiopathic Pulmonary Fibrosis

Idiopathic Pulmonary Fibrosis (IPF) now has two licensed treatments available. Pirfenidone was the first drug to be licensed and approved for use, followed by nintedanib. We set out our real world experience with these agents in terms of their adverse events profile outside the restrictions of a cli...

Descripción completa

Detalles Bibliográficos
Autores principales: Hughes, Gareth, Toellner, Hannah, Morris, Helen, Leonard, Colm, Chaudhuri, Nazia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5039481/
https://www.ncbi.nlm.nih.gov/pubmed/27598213
http://dx.doi.org/10.3390/jcm5090078

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5039481/
https://www.ncbi.nlm.nih.gov/pubmed/27598213
http://dx.doi.org/10.3390/jcm5090078

Ejemplares similares